VepressClinical, Cosmetic and Investigational Dermatology 2018:DovepressDovepressDupilumab assessment with the literatureNotes: aSubjectsVepressClinical, Cosmetic and Investigational Dermatology

VepressClinical, Cosmetic and Investigational Dermatology 2018:DovepressDovepressDupilumab assessment with the literatureNotes: aSubjectsVepressClinical, Cosmetic and Investigational Dermatology 2018:DovepressDovepressDupilumab evaluation of the literatureNotes: aSubjects have been adults older than 18 years with moderate-to-severe…